Exploring the state- and allele-specific conformational landscapes of Ras: understanding their respective

Hui Wang1, Dan Liu1, Yongkui Yu1

  • 1MOE Key Laboratory for Cellular Dynamics and School of Life Sciences, University of Science and Technology of China, Hefei 230027, China. dlong@ustc.edu.cn.

Insights

Ras protein dynamics reveal vulnerable pockets for cancer drug development. Understanding these conformational changes is key for creating effective, allele-specific Ras inhibitors.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Pharmacology

Background:

  • Ras proteins are key regulators of cell signaling, and their mutations are major drivers of cancer.
  • Targeting Ras directly is challenging due to its dynamic nature and the need for allele-specific strategies.
  • The impact of oncogenic mutations and activation states on Ras dynamics and drug accessibility remains poorly understood.

Purpose of the Study:

  • To characterize how nucleotide state and specific mutations alter Ras protein dynamics.
  • To investigate the free energy landscape governing Ras conformational changes and druggability.
  • To identify mechanisms affecting the accessibility of cryptic pockets for inhibitor binding.

Main Methods:

  • Utilized a combination of Nuclear Magnetic Resonance (NMR) experiments and computational approaches.
  • Constructed quantitative ensembles to model Ras conformational dynamics.
  • Analyzed the accessibility of cryptic pockets (SI/II-P and SII-P) in different Ras states and mutants.

Main Results:

  • Identified conserved cryptic pockets (SI/II-P and SII-P) across different Ras states and alleles.
  • Revealed that local conformational changes reduce the accessibility of the SII-P pocket, particularly for Ras·GTP and Ras(G12D)·GDP.
  • Observed low reactivity of these Ras forms with covalent SII-P inhibitors due to impaired pocket accessibility.

Conclusions:

  • Ras dynamics are altered by nucleotide state and mutations, influencing inhibitor binding.
  • Conformational selection is a likely mechanism for Ras-binder interactions.
  • Findings provide insights for developing state- and allele-specific, as well as pan-Ras, inhibitors.

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
6.4K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
4.1K
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
2.1K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
855
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.3K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.0K